Sequoia-backed genetic diagnostics company MedGenome raised $55 million in an investment round led by LeapFrog Investments. Existing investors Sofina and Sequoia also participated in the round.
This investment will be utilised to expand the clinical genomic testing market by expanding access in Tier-II and Tier-III towns and cities across India and accelerate the company’s drug discovery programmes.
“Genomics and personalised medicine are the future of healthcare, but emerging markets remain significantly under-penetrated. As the largest player in India in applied genomics, we are well-positioned to fill this gap,” said Sam Santhosh, CEO and founder of MedGenome.
The Indian genetic diagnostics